Clinical Trial

Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To determine whether peripheral low dose systemic thrombolysis (PLST) is non-inferior to catheter directed acoustic pulse thrombolysis (ACDT) in improving RV function and reducing pulmonary artery pressures in submassive pulmonary embolism (PE)
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2018-06-26; most recent amendment 2024-10-01.
Status change: Completed → Active, Not Recruiting 2024-10-01
Status change: Active, Not Recruiting → Completed 2023-03-19
Status change: Recruiting → Active, Not Recruiting 2022-04-04
Status change: Not Yet Recruiting → Recruiting 2019-01-27
Trial Details
NCT Number NCT03581877
Lead Sponsor Northwell Health
Conditions Pulmonary Embolism, Pulmonary Hypertension, Thromboembolism, Right Ventricular Dysfunction
Enrollment 31 participants
Start Date 2019-01-28
Primary Completion 2023-03-19 (estimated)
Study Completion 2025-03-19 (estimated)
Updated on ClinicalTrials.gov 2024-10-03